Vericel Corp Ord Stock Investor Sentiment

VCEL Stock  USD 39.53  4.07  11.48%   
About 66 percent of all Vericel Corp's institutional investors are curious in acquiring. The analysis of the overall investor sentiment regarding Vericel Corp Ord suggests that many traders are confidant. Vericel Corp's investing sentiment shows overall attitude of investors towards Vericel Corp Ord.

Comfort Level 66

 Interested

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Vericel Corp's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Vericel Corp Ord.

Vericel Historical Sentiment

Although Vericel Corp's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Vericel, such as negative comments on social media and news outlets, may cause fear in the market and push Vericel Corp's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Vericel.

Vericel Corp Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Vericel Corp can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Vericel Corp Ord Historical Investor Sentiment

Investor biases related to Vericel Corp's public news can be used to forecast risks associated with an investment in Vericel. The trend in average sentiment can be used to explain how an investor holding Vericel can time the market purely based on public headlines and social activities around Vericel Corp Ord. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Vericel Corp's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Vericel Corp and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Vericel Corp news discussions. The higher the estimate score, the more favorable the investor's outlook on Vericel Corp.

Vericel Corp Maximum Pain Price Across October 17th 2025 Option Contracts

Vericel Corp's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Vericel Corp close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Vericel Corp's options.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of Vericel Corp's Stock prices. Below is the latest headlines and news related to Vericel Corp Ord Stock. The global stock market is bearish. About 62% of major world exchanges and indexes are down. See today's market update for more information.
There is far too much social signal, news, headlines, and media speculation about Vericel Corp that are available to investors today. This information is accessible both publicly - through Vericel Corp's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Vericel-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Vericel Corp news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Vericel Corp relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Vericel Corp's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Vericel Corp alpha.

Vericel Largest EPS Surprises

Earnings surprises can significantly impact Vericel Corp's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-08-01
2024-06-30-0.08-0.1-0.0225 
2020-05-05
2020-03-31-0.08-0.1-0.0225 
2024-11-07
2024-09-30-0.05-0.020.0360 
2024-05-08
2024-03-31-0.11-0.080.0327 
2022-05-04
2022-03-31-0.12-0.15-0.0325 
2021-05-05
2021-03-31-0.04-0.07-0.0375 
View All Earnings Estimates
few days ago at gurufocus.com         
Vericel to Report Second-Quarter 2025 Financial Results on July 31, 2025 VCEL Stock News
Gurufocus Stories at Macroaxis
few days ago at gurufocus.com         
Vericel Corp Announces Upcoming Q2 2025 Financial Results Release VCEL stock news
Gurufocus Stories at Macroaxis
over a week ago at thelincolnianonline.com         
Vericel Corporation Shares Bought by New York State Common Retirement Fund
news
over a week ago at thefly.com         
Vericel price target lowered by 7 at BTIG, heres why VCEL
news
over a week ago at gurufocus.com         
Vericel Price Target Cut by BTIG Amidst MedTech Sector Challenges VCEL Stock News
Gurufocus Stories at Macroaxis
over a week ago at thelincolnianonline.com         
Vericel Corporation Shares Purchased by Valeo Financial Advisors LLC
news
over three weeks ago at thelincolnianonline.com         
Vericel Corporation Shares Purchased by Lisanti Capital Growth LLC
news
over a month ago at finance.yahoo.com         
If EPS Growth Is Important To You, Vericel Presents An Opportunity
Yahoo News
over a month ago at kalkinemedia.com         
Stem Cell Therapy Market to Surpass 45.6 Billion by 2033, Fueled by Regenerative Innovations DataM I...
news
over a month ago at thelincolnianonline.com         
Conestoga Capital Advisors LLC Sells 7,830 Shares of Vericel Co.
news
over a month ago at simplywall.st         
Does Vericel Deserve A Spot On Your Watchlist?
Simply Wall St News at Macroaxis
over a month ago at gurufocus.com         
Vericel Analyst Reiterates Overweight Rating with Stable Price Target VCEL Stock News
Gurufocus Stories at Macroaxis
over a month ago at thelincolnianonline.com         
Vericel Co. Receives Average Recommendation of Buy from Analysts
news
over a month ago at gurufocus.com         
Vericel to Present at the Truist Securities MedTech Conference o
Gurufocus Stories at Macroaxis
over a month ago at thelincolnianonline.com         
Congress Asset Management Co. Purchases 22,579 Shares of Vericel Co.
news
There is far too much social signal, news, headlines, and media speculation about Vericel Corp that are available to investors today. This information is accessible both publicly - through Vericel Corp's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Vericel-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Vericel Corp news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Vericel Corp relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Vericel Corp's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Vericel Corp alpha.

Vericel Corp Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Acquisition by Karen Mahoney of 5175 shares of Vericel Corp subject to Rule 16b-3
04/30/2025
2
Vericel raises 2025 profitability guidance amid strong MACI Arthro launch
05/08/2025
3
Acquisition by Colangelo Dominick of 14062 shares of Vericel Corp at 2.65 subject to Rule 16b-3
05/14/2025
4
Acquisition by Colangelo Dominick of 14063 shares of Vericel Corp at 2.65 subject to Rule 16b-3
05/15/2025
5
Lazard Asset Management LLC Purchases 5,923 Shares of Vericel Co.
05/20/2025
6
Acquisition by Hopper Jonathan Mark of 10000 shares of Vericel Corp at 18.0 subject to Rule 16b-3
06/02/2025
7
Conestoga Capital Advisors LLC Sells 7,830 Shares of Vericel Co.
06/17/2025
8
Vericel price target lowered by 7 at BTIG, heres why VCEL
07/14/2025
9
Vericel to Report Second-Quarter 2025 Financial Results on July 31, 2025 VCEL Stock News
07/17/2025
When determining whether Vericel Corp Ord is a strong investment it is important to analyze Vericel Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Vericel Corp's future performance. For an informed investment choice regarding Vericel Stock, refer to the following important reports:
Check out Vericel Corp Hype Analysis, Vericel Corp Correlation and Vericel Corp Performance.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vericel Corp. If investors know Vericel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vericel Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.476
Earnings Share
0.05
Revenue Per Share
4.84
Quarterly Revenue Growth
0.026
Return On Assets
(0)
The market value of Vericel Corp Ord is measured differently than its book value, which is the value of Vericel that is recorded on the company's balance sheet. Investors also form their own opinion of Vericel Corp's value that differs from its market value or its book value, called intrinsic value, which is Vericel Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vericel Corp's market value can be influenced by many factors that don't directly affect Vericel Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vericel Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vericel Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vericel Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.